Nicholas Investment Partners’s Biohaven BHVN Stock Holding History

Nicholas Investment Partners’s Portfolio BHVN Stock Details BHVN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q1	–	Sell	-18,673	Closed	-$697K	–	196
2024 Q4	$697K	Sell	18,673 -6,776	-27%	-$316K	0.06%	200
2024 Q3	$1.27M	Sell	25,449 -20,517	-45%	-$798K	0.12%	176
2024 Q2	$1.6M	Sell	45,966 -136,697	-75%	-$5.4M	0.17%	151
2024 Q1	$9.99M	Buy	182,663 +63,151	+53%	+$3.13M	1.02%	21
2023 Q4	$5.12M	Sell	119,512 -473,035	-80%	-$14.7M	0.6%	64
2023 Q3	$15.4M	Buy	592,547 +167,547	+39%	+$3.48M	1.15%	31
2023 Q2	$10.2M	Sell	425,000 -475,270	-53%	-$8.18M	0.7%	43
2023 Q1	$12.3M	Buy	+900,270	New	+$14.3M	0.93%	36

Other funds holding BHVN

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

Stifel Financial St. Louis, Missouri $109B AUM 21.36% 1-Year Est. Return

SCM

Suvretta Capital Management New York $3.92B AUM 86.67% 1-Year Est. Return

FCM

Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

RP Management New York $139M AUM 37.98% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return

Nicholas Investment Partners's BHVN Position: Q1 2025 in Review

Nicholas Investment Partners sold out of Biohaven (BHVN) in Q1 2025, closing a stake of 18,673 shares — an estimated $697K sold.

Nicholas Investment Partners first reported a position in BHVN in Q1 2023 and held it in 8 quarters. The position peaked at $15.4M in Q3 2023. 266 funds tracked by Wall St. Rank hold BHVN as of Q1 2025.

Nicholas Investment Partners reported no remaining Biohaven position as of Q1 2025 after selling out during the quarter.
Nicholas Investment Partners sold 18,673 Biohaven shares in Q1 2025, an estimated $697K.
Nicholas Investment Partners first reported a position in Biohaven in Q1 2023 and held it in 8 quarters.
Nicholas Investment Partners's Biohaven position peaked at $15.4M in Q3 2023.
266 funds tracked by Wall St. Rank held Biohaven as of Q1 2025.

Based on Nicholas Investment Partners's 13F filing for Q1 2025, filed 15 May 2025.